MWMinjie Wang

Minjie Wang

*This is an algorithmically generated author record based on publicly available information.

Minjie Wang has a total of 44 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Natural Course and Clinical Outcomes of Patients With Hemorrhagic Moyamoya Disease

    by Cheng Chen, Gan Gao, Hui Wang, Qian Zhang, Heguan Fu, Zhengxing Zou, Rong Hui Gu, Shuainan Ning, Zhangwei Zeng, Minjie Wang, et al.

  • Open Access

    Integrated Serum Multiomics Reveal Subtype‐Specific Immune Dysregulation and Sex‐Dimorphic Pathophysiology in Moyamoya Disease

    by Qingbao Guo, Manli Xie, Cong Han, Jingjie Li, Qian‐Nan Wang, Gan Gao, Simeng Liu, Fangbin Hao, Minjie Wang, Xiaopeng Wang, et al.

    Background: Moyamoya disease (MMD) is a rare cerebrovascular disorder with unknown pathogenesis, partly due to limited access to human cerebral vascular tissue and suitable animal models. Using a large biobank of frozen serum samples, this study aimed to explore molecular signatures of ischemic and hemorrhagic MMD. Methods: Serum from 30 patients with MMD (18 ischemic, 12 hemorrhagic) and 30 matched healthy controls underwent proteomic and metabolomic profiling. Data were analyzed for differential expression, pathway enrichment, and protein–metabolite networks, with adjustment for age, sex, and body mass index. Results: In a separate large Chinese cohort (n=6167), female patients had a higher proportion of hemorrhagic MMD (19.9% versus 16.9%) and a higher prevalence of anterior choroidal artery dilation (15.1% versus 13.2%) than male patients (both P <0.05). At the molecular level, ischemic MMD showed complement C4‐B deficiency and disrupted natural killer cell cytotoxicity; both subtypes shared immunoglobulin perturbations (eg, decreased heavy‐chain variable regions). Sex‐specific alterations included anti–folate‐binding protein, serum amyloid A2, glycolithocholic acid, and estradiol. All omics data are publicly accessible. Conclusions: Integrated serum multiomics defines distinct immune‐related signatures for ischemic and hemorrhagic MMD and reveals sex‐dimorphic molecular pathways. These findings, together with clinical sex differences in disease subtype and vascular anatomy, provide a framework for personalized, sex‐aware management of MMD.

  • Open Access

    Clinical and genetic risk factors and long-term outcomes of MRI vessel wall enhancement in moyamoya disease

    by Fang-Bin Hao, Cong Han, Mingming Lu, Yue Wang, Gan Gao, Qian-Nan Wang, Shitong Liu, Si-Meng Liu, Min-Jie Wang, Ri-Miao Yang, et al.

    Background: Intracranial vessel wall enhancement (VWE) on high-resolution magnetic resonance imaging (HRMRI) is associated with the progression and poor prognosis of moyamoya disease (MMD). However, the genetic background and risk factors for VWE in MMD have not been investigated. Therefore, this study assessed potential risk factors for VWE in MMD. Methods: We evaluated MMD patients using HRMRI and traditional angiography examinations. The participants were divided into VWE group and non-VWE group based on the presence or absence of VWE on HRMRI. Logistic regression was performed to compare the risk factors for VWE in MMD. The incidence of cerebrovascular events of the different subgroups according to risk factors were compared using Kaplan – Meier survival and Cox regression.. STROBE (Strengthening the Reporting of Observational Studies in Epidemiology) guidelines were followed for reporting our cohort study. Results: We included 283 MMD patients, 84 of whom had VWE on HRMRI. The VWE group had higher modified Rankin Scale scores at admission ( P = 0.014) and a higher incidence of ischemia and hemorrhage ( P =0.002) than did the non-VWE group. Multiple logistics regression shows risk factors for VWE included the ring finger protein 213 ( RNF213 ) pR4810K variant (OR: 2.01 [95% confidence interval (CI), 1.08 - 3.76]; P = 0.028), hyperhomocysteinemia (HHcy; OR: 5.08 [95% CI, 2.34 - 11.05], P < 0.001), and smoking history (OR, 3.49 [95% CI, 1.08-11.31], P = 0.037). During the follow-up of 63.9 ± 13.2 months (medium 65 months), 18 recurrent stroke events occurred. Cox regression showed that VWE and RNF213 pR4810K variant were risk factors for follow-up stroke. Conclusion: The RNF213 p.R4810K variant is strongly associated with VWE and poor prognosis in MMD. HHcy and smoking are independent risk factors for VWE; both are likely to induce the VWE phenomenon by affecting vascular endothelial function or causing vascular endothelial damage.